SCHEMBL7976080

SCHEMBL7976080

O=C(O)C(Cc1ccc2c(c1)OCO2)C(O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.52
CYP2D6 P10635 1/20 0.50
LMNA P02545 1/20 0.49
ALDH1A1 P00352 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
SLC6A4 P31645 2/20 0.49
HPGD P15428 2/20 0.48
RAB9A P51151 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
NPC1 O15118 1/20 0.48
TRPM8 Q7Z2W7 1/20 0.47
TAAR1 Q96RJ0 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4997864 0.86 LMNA (0.59) CYP3A4CYP2D6LMNAALDH1A1CYP1A2
SCHEMBL14377906 0.86 CYP3A4 (0.61) CYP3A4CYP2D6ALDH1A1CYP1A2CYP2C19
SCHEMBL4329251 0.86 CYP3A4 (0.61) CYP3A4CYP2D6ALDH1A1CYP1A2CYP2C19
SCHEMBL7993756 0.86 ACE (0.53) CYP3A4CYP2D6LMNAALDH1A1HPGD
SCHEMBL30052034 0.79 CYP3A4 (0.62) CYP3A4CYP2D6LMNAALDH1A1CYP1A2
SCHEMBL2457093 0.79 CYP3A4 (0.62) CYP3A4CYP2D6LMNAALDH1A1CYP1A2
SCHEMBL8953616 0.79 CYP3A4 (0.62) CYP3A4CYP2D6LMNAALDH1A1CYP1A2
SCHEMBL7516082 0.79 CYP3A4 (0.62) CYP3A4CYP2D6LMNAALDH1A1CYP1A2
SCHEMBL9234310 0.79 RAB9A (0.52) CYP3A4CYP2D6LMNAALDH1A1CYP1A2
SCHEMBL7307051 0.78 CYP3A4 (0.63) CYP3A4CYP2D6LMNAALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207686-B1 FOR THERAPY OF HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
WO-1996015109-A1 ENDOTHELIN ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-05-23 WO disclosed